Filing Flows › Covista (CVSA) › Q1 FY27 › vs Q4 FY26
Covista (CVSA) Q1 FY27 vs Q4 FY26 (quarter over quarter)
Covista's revenue rose $10.2M (+2%) from $501M in Q4 FY26 to $512M in Q1 FY27. The biggest changes: Walden +$5.8M (+3%); Chamberlain +$2.2M (+1%); Medical and Veterinary +$2.1M (+2%). Operating margin 19.2% against 19.0% (+0.1 pts).
Covista, Q1 FY27: revenue $512M (+11% year over year), operating margin 19.2%, net earnings $67.4M, operating cash flow $114M. The chart draws each line against Q4 FY26, the increases inside each band.
Margins
| Q1 FY27 | Q4 FY26 | Change | |
|---|---|---|---|
| Operating margin | 19.2% | 19.0% | +0.1 pts |
| Net margin | 13.2% | 14.3% | -1.1 pts |
| Free cash flow margin | 14.9% | 19.4% | -4.4 pts |
Every line
| Line | Q1 FY27 | Q4 FY26 | Change | % |
|---|---|---|---|---|
| Walden | $217M | $211M | $5.8M | +3% |
| Chamberlain | $192M | $190M | $2.2M | +1% |
| Medical and Veterinary | $102M | $100M | $2.1M | +2% |
| Revenue | $512M | $501M | $10.2M | +2% |
| Operating profit | $98.0M | $95.4M | $2.6M | +3% |
| Costs & expenses | $414M | $406M | $7.6M | +2% |
| Pre-tax earnings | $85.4M | $88.0M | −$2.5M | -3% |
| Other expense, net | $12.6M | $7.5M | $5.1M | +68% |
| Cost of revenue | $221M | $217M | $4.0M | +2% |
| SG&A | $193M | $188M | $4.5M | +2% |
| Net earnings | $67.4M | $71.7M | −$4.3M | -6% |
| Income tax | $18.0M | $16.2M | $1.8M | +11% |
| Depreciation & amortization | $12.3M | $14.0M | −$1.8M | -13% |
| Share-based compensation | $8.2M | $10.1M | −$1.9M | -19% |
| Working capital & other | $26.2M | $28.1M | −$1.9M | -7% |
| Operating cash flow | $114M | $124M | −$9.9M | -8% |
| Free cash flow (OCF − capex) | $76.4M | $97.1M | −$20.7M | -21% |
| Capital expenditures | $37.6M | $26.8M | $10.8M | +40% |
Questions
How much did Covista's revenue grow quarter over quarter in Q1 FY27?
Covista's revenue rose $10.2M (+2%) from $501M in Q4 FY26 to $512M in Q1 FY27.
What drove Covista's revenue change in Q1 FY27?
Walden +$5.8M (+3%); Chamberlain +$2.2M (+1%); Medical and Veterinary +$2.1M (+2%).